US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Interim Report 1 January – 31 March 2026: Signs of stabilisation in the first quarter and improved underlying earnings

First quarter 2026 • Net sales SEK 363.3 million (351.5) • EBITA SEK 9.3 million (10.4), adjusted for non-recurring items SEK 10.7 million (10.4) • EBITA margin 2.6 percent (3.0), adjusted for non-recurring items 2.9 percent (3.0) • EBIT SEK 7.2 million (8.0) • EBIT margin 2.0 percent (2.3) • Profit after financial items SEK 10.2 million (8.6) • Profit for the period SEK 7.9 million (6.9) • Basic and diluted earnings per share SEK 0.82 (0.72)     Performance measures     Q1 Q1 Full-year

Dedicares Annual and Sustainability Report 2025 is now available on the website

Please find the Annual and Sustainability Report here .   This information is mandatory for Dedicare AB (publ) to publish pursuant to the Swedish Securities Market Act. This information was submitted for publication through the agency of the contact persons set out below at 10:00 a.m. CEST on 15 April 2026.   For more information, please contact: Bård Kristiansen, CEO & Managing Director, +47 97 08 88 83 Anette Sandsjö, CFO, +46 (0)73 343 4468   Dalagatan 100, 5th floor 113 43 Stockholm Sweden

Year-end Report 1 January – 31 December 2025: Dedicare strengthens its competitive position in a continued challenging market

Fourth quarter 2025 • Net sales SEK 361.8 million (389.0) • EBITA SEK 13.1 million (19.5), adjusted for non-recurring items SEK 16.3 million (12.8) • EBITA margin 3.6 percent (5.0), adjusted for non-recurring items 4.5 percent (3.3) • EBIT SEK 10.9 million (17.2), adjusted for non-recurring items SEK 14.1 million (10.6) • EBIT margin 3.0 percent (4.4), adjusted for non-recurring items 3.9 percent (2.7) • Profit after financial items SEK 10.9 million (17.7) • Profit for the period SEK 7.5 million (14.4) • Basic earnings per share 0.78 SEK (1.51) • Diluted earnings

Dedicare Updates Profitability Target

The Board of Directors of Dedicare AB (publ) has decided to update the company’s financial profitability target. The long-term EBITA margin target has been changed to 6 percent over time, from the previous target of 7 percent. The decision is based on changed market conditions, including lower demand, increased competition, and rising price pressure. In response, Dedicare has broadened its operations - both geographically and through an expanded service offering - with the aim of strengthening the company’s long-term competitiveness and building a more diversified business model. The

Interim Report 1 January – 30 September 2025: Dedicare strengthens positioning through strategic initiatives under still-challenging market conditions

Third quarter 2025 • Net sales SEK 389.9 million (460.9) • EBITA SEK 13.9 million (11.2), adjusted for non-recurring items SEK 13.9 million (19.0) • EBITA margin 3.6 percent (2.4), adjusted for non-recurring items 3.6 percent (4.1) • EBIT SEK 11.7 million (9.0), adjusted for non-recurring items SEK 11.7 million (16.8) • EBIT margin 3.0 percent (2.0), adjusted for non-recurring items 3.0 percent (3.6) • Profit after financial items SEK 11.7 million (8.9) • Profit for the period SEK 9.6 million (6.9) • Basic earnings per share SEK 1.01 (0.72) • Diluted earnings per

Interim Report 1 January – 30 June 2025: Dedicare is winning market shares and investing in new business segments in a market that remains challenging

Second quarter 2025 • Net sales SEK 351.7 million (439.6) • EBITA SEK 13.1 million (21.2), adjusted for non-recurring items SEK 14.0 million (24.1) • EBITA margin 3.7 percent (4.8), adjusted for non-recurring items 4.0 percent (5.5) • EBIT SEK 10.8 million (18.9), adjusted for non-recurring items SEK 11.7 million (21.8) • EBIT margin 3.1 percent (4.3), adjusted for non-recurring items 3.3 percent (5.0) • Profit after financial items SEK 11.7 million (19.6) • Profit for the period SEK 9.1 million (15.3) • Basic earnings per share SEK 0.95 (1.60) • Diluted earnings

Interim Report 1 January – 31 March 2025: A still-challenging market in the first quarter of 2025

First quarter 2025 • Net sales SEK 351.5 million (430.2) • EBITA SEK 10.4 million (17.4) • EBITA margin 3.0 percent (4.0) • EBIT SEK 8.0 million (15.1) • EBIT margin 2.3 percent (3.5) • Profit after financial items SEK 8.6 million (13.5) • Profit for the period SEK 6.9 million (10.5) • Basic earnings per share SEK 0.72 (1.09) • Diluted earnings per share SEK 0.72 (1.08)     Performance measures      Chief Executive Officer’s statement   “A still-challenging market in the first quarter of 2025”   Purchasing of healthcare

Dedicares Annual and Sustainability Report 2024 is now available on the website

Please find the Annual and Sustainability Report here .   This information is mandatory for Dedicare AB (publ) to publish pursuant to the Swedish Securities Markets Act. This information was submitted for publication through the agency of the below contact at 3:00 p.m. CET on 24 March 2025.   For more information, please contact: Bård Kristiansen, CEO & Managing Director, +47 97 08 88 83 Anette Sandsjö, CFO, +46 (0)73 343 4468   Ringvägen 100, entrance E, 10th floor 118 60 Stockholm Sweden +46 (0)

Year-end Report 1 January – 31 December 2024: Continued weak progress in the fourth quarter concluded a challenging 2024

Fourth quarter 2024 • Net sales SEK 389.0 million (464.1) • EBITA SEK 19.5 million (41.6), adjusted for non-recurring items SEK 12.8 million (30.7) • EBITA margin 5.0 percent (9.0), adjusted for non-recurring items 3.3 percent (6.6) • EBIT SEK 17.2 million (39.3), adjusted for non-recurring items SEK 10.6 million (28.4) • EBIT margin 4.4 percent (8.5), adjusted for non-recurring items 2.7 percent (6.1) • Profit after financial items SEK 17.7 million (41.5) • Profit for the period SEK 14.4 million (33.7) • Basic earnings per share SEK 1.51 (3.53) • Diluted earnings

Interim Report 1 January – 30 September 2024: Market still challenging in the third quarter

Third quarter 2024 • Net sales SEK 460.9 million (524.5) • EBITA SEK 11.2 million (40.6), adjusted for non-recurring items SEK 19.0 million (40.6) • EBITA margin 2.4 percent (7.7), adjusted for non-recurring items 4.1 percent (7.7) • EBIT SEK 9.0 million (36.7), adjusted for non-recurring items SEK 16.8 million (36.7) • EBIT margin 2.0 percent (7.0), adjusted for non-recurring items 3.6 percent (7.0) • Profit after financial items SEK 8.9 million (37.2) • Profit for the period SEK 6.9 million (29.2) • Basic earnings per share SEK 0.72 (3.05) • Diluted earnings per

Interim Report 1 January – 30 June 2024: A still-challenging market burdened the second quarter

Second quarter 2024 · Net sales SEK 439.6 million (478.9) · EBITA SEK 21.2 million (38.0), adjusted for non-recurring items SEK 24.1 million (38.0) · EBITA margin 4.8 percent (7.9), adjusted for non-recurring items 5.5 percent (7.9) · EBIT SEK 18.9 million (34.4), adjusted for non-recurring items SEK 21.8 million (34.4) · EBIT margin 4.3 percent (7.2), adjusted for non-recurring items 5.0 percent (7.2) · Profit after financial items SEK 19.6 million (29.8) · Profit for the period SEK 15.3 million (22.9) · Basic earnings per share SEK 1.60 (2.40) · Diluted

Dedicare Implements Management Changes in Sweden and Initiates Cost-Saving Program

Dedicare is undergoing a management change in Sweden, where Bård Kristiansen, CEO of Dedicare Norway since 2017, will take over as interim CEO for Dedicare Sweden. Bård will continue as CEO for Dedicare Norway, while Lene Langås, operational manager within nurse staffing since 2013, will be appointed as interim operational manager for the Norwegian operations. The process of recruiting a new CEO for Dedicare Sweden will commence immediately. Eva Brunnberg is leaving the company, at her own request, and thereby vacating the position of CEO for Dedicare Sweden. "Bård has successfully built

Dedicare updates profitability target for 2024

Dedicare has had a financial profitability target of its EBIT margin exceeding 7.0 percent. Its Board of Directors has decided to change its profitability target to an EBITA margin of 7.0 percent over time.   Dedicare’s strategy is acquisition-led growth. The reason for this change is to enable the monitoring of profitability performance without the effect of acquisition-related assets. The transfer to an EBITA-based metric is also consistent with how other major staffing and consulting firms monitor their profitability targets, so it increases comparability with other companies on

Dedicare adjusts segment reporting

Dedicare is changing the allocation of costs in its segment structure from its First-quarter Interim Report 2024 onwards. In the previous segment reporting, shareholder-related expenses were allocated between all segments. Effective the first quarter 2024, all these expenses will be reported in the Group-wide segment. Shareholder expenses are costs arising due to ownership/management of shares and the company’s listing on Nasdaq. Dedicare’s opinion is that all these expenses should be charged to the Group-wide segment to give a fairer view. Segment reporting for 2023 has been recalculated

Interim Report 1 January – 31 March 2024: A challenging start to 2024

First quarter 2024 • Net sales SEK 430.2 million (503.2) • EBITA SEK 17.4 million (41.6) • EBITA margin 4.0 percent (8.3) • EBIT SEK 15.1 million (38.0) • EBIT margin 3.5 percent (7.6) • Profit after financial items SEK 13.5 million (31.3) • Profit for the period SEK 10.5 million (24.5) • Basic earnings per share SEK 1.09 (2.57) • Diluted earnings per share SEK 1.08 (2.55)     Performance measures     Chief Executive Officer’s statement   It was a challenging start on all Nordic markets in 2024, and the first quarter of the year

Dedicares Annual and Sustainability Report 2023 is now available on the website

Please find the Annual and Sustainability Report here.  This information is mandatory for Dedicare AB (publ) to publish pursuant to the Swedish Securities Markets Act. This information was submitted for publication through the agency of the below contact at 8 a.m. CET on 22 March 2024. For more information, please contact: Krister Widström, CEO & Managing Director, +46 (0)70 526 7991Anette Sandsjö, CFO, +46 (0)73 343 4468 Ringvägen 100, entrance E, 10th floor118 60 StockholmSweden+46 (0)8 555 65600www.

Year-end Report 1 January – 31 December 2023: Continued growth and healthy profitability sum up an intensive year

Fourth quarter 2023 • Net sales SEK 464.1 million (499.3) • EBITDA SEK 44.1 million (37.9), adjusted for non-recurring items, SEK 33.2 million (40.6) • EBITDA margin 9.5 percent (7.6), adjusted for non-recurring items, 7.2 percent (7.6) • EBIT SEK 39.3 million (31.3), adjusted for non-recurring items, SEK 28.4 million (34.0) • EBIT margin 8.5 percent (6.2), adjusted for non-recurring items, SEK 6.1 percent (6.7) • Profit after financial items SEK 41.5 million (29.9) • Profit for the period SEK 33.7 million (25.1) • Basic earnings per share SEK 3.53 (2.64) •

Dedicare launches Dedicare International – innovative offering for Nordic healthcare professionals to work abroad

Dedicare, the Nordic region’s largest recruitment and staffing provider in healthcare, life science and social work, announces today the launch of its groundbreaking concept – Dedicare International. This initiative targets healthcare professionals in the Nordic region aspiring to work internationally and signifies a strategic milestone in Dedicare's growth journey towards becoming one of Europe's leading recruitment and staffing providers.    Dedicare International specifically targets nurses, doctors, and social workers in the Nordic region who are interested in international career

Dedicare established as a brand on the UK market

Dedicare's UK subsidiary, the specialist healthcare recruitment agency Templars Medical Agency, has changed its company name to Dedicare Healthcare Ltd. The name change means that Dedicare AB (publ) takes a further step in establishing Dedicare on the European market for recruitment and staffing in healthcare, life science and social work. - We are very proud and happy to launch the Dedicare brand on the UK market. Continuing the expansion of the brand in Europe is part of our growth strategy and the work to achieve our vision of becoming one of Europe’s leading recruitment and staffing

Dedicare acquires recruitment and staffing company in the UK

Dedicare signed an agreement today to acquire UK recruitment and staffing company Templars Medical Agency Ltd. This company recruits and provides doctors for customers in the UK and Ireland. The acquisition will complete on 1 October 2022.”Acquiring Templars Medical Agency is fully consistent with Dedicare’s growth strategy and vision of becoming one of Europe’s leading recruitment and staffing companies in healthcare, life sciences and social work. It will further consolidate our positioning in Europe, but first and foremost, bring us a platform in the UK and Ireland,” commented Krister

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe